Home > Journals > Minerva Urologica e Nefrologica > Past Issues > Minerva Urologica e Nefrologica 2005 March;57(1) > Minerva Urologica e Nefrologica 2005 March;57(1):9-16

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

MINERVA UROLOGICA E NEFROLOGICA

A Journal on Nephrology and Urology


Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 0,536


eTOC

 

REVIEWS  


Minerva Urologica e Nefrologica 2005 March;57(1):9-16

language: English

Metabolic abnormalities and the medical management of calcium oxalate nephrolithiasis

Chandhoke P. S.

Department of Surgery (Urology) and Medicine (Renal Diseases) University of Colorado Health Sciences Center, Denver, CO, USA


PDF  


The lifetime prevalence of urolithiasis is approximately 12% for men and 7% for women in the United States and seems to be increasing; the cost of managing kidney stones continues to escalate. The most common kidney stones continue to be composed primarily of calcium and are an admixture of phosphate and oxalate. Of these, calcium oxalate stones are the most predominant. This review will focus only on the pathogenesis and medical management of calcium oxalate stones.

top of page

Publication History

Cite this article as

Corresponding author e-mail